chrisvoncsefalvay/vaers-outcomes huggingface dataset:
symptoms were mild; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (symptoms were mild) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (symptoms were mild). At the time of the report, VACCINATION COMPLICATION (symptoms were mild) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.   This case was linked to MOD-2021-406646, MOD-2021-406647 (Patient Link).
This spontaneous report as received from a other health professional refers to a patient of unknown gender and age. No concurrent condition or medical history was reported. On 02-JUN-2015 the patient was vaccinated with an improperly stored dose of VARIVAX (L00454: Exp date 06-JAN-2017) (Concentration, dose # and route of administration were not reported). No adverse experience reported. Additional information has been requested.
Information has been received from a nurse practitioner (N.P.) concerning a 62 year old male patient with a history of chickenpox who on 26-SEP-2008 was vaccinated with a single dose of ZOSTER (Oka/Merck).  Subsequently, the patient developed shingles on 13-OCT-2008.  The patient sought unspecified medical attention.  At the time of report, the outcome of shingles was unknown.  Follow-up information has been received from a nurse practitioner (N.P.).  Concomitant medication included COUMADIN and HYTRIN.  It was reported that the herpes ZOSTER began on 13-OCT-2008.  There was no recent exposure to chickenpox or shingles.  The patient reported pain of a 7 on a scale of 1 to 10.  No additional information was available.  Additional information has been requested.
Shivers, low temperature, headache, joint and muscle aches; 6-7 hours sleep, 2 acetaminophen.
Narrative:  Patient with two doses of covid vaccine. Death reported thus submitting per network guidance. Patient with PMH of HFrEF s/p AICD, HTN, CAD, CKD, COPD, and neuroendocrine tumor. Patient had autopsy requested on March 3rd, 2021. No direct reactions reported related to vaccine.
High fever 130.2for 24 hours. Went down to 102. Third day very bad diarria.
diarrhea; vomiting; has become sick from her two month old baby, who received ROTATEQ; This spontaneous report was received from a pharmacist who refers to her dautgher, a 31-year-old non-pregnant female patient. There was no information about the patient' concurrent conditions, concomitant medications and medical history provided.  On 08-SEP-2021, the patient's child was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) for prophylaxis, orally (exact dose, lot number and expiration date were not provided).  On 15-SEP-2021 (reported as one week after the child being vaccinated ), the patient became sick from her two month old baby, who received rotavirus vaccine, live, oral, pentavalent (ROTATEQ) by shedding and transmission of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) to non-vaccinated person through the babies stool on an unknown date in September 2021. The patient experienced diarrhea and vomiting for two constant days. The two month old infant was not experiencing any adverse events after vaccination with rotavirus vaccine, live, oral, pentavalent (ROTATEQ).   The outcome of the event was unknown. The causality assessment was not provided.
On 12-22-11 client & mom came to WIC office. He had pinpoint red raised rah all over. Cheeks were deeper red than elsewhere. Rash was on arms, chest, back belly & legs. No fever, but not eating well. On 12-29-11 mom called the HD. His (L) leg was red, hard, tender and getting bigger.
Severe headache, 102-103 fever, significant neck and shoulder pain, significant joint pain. 24 hours.
Loss of appetite within 24 hours, Severe diarrhea within 48 hours. Diarrhea lasted for 24 hours. Extreme fatigue
I had a supraventricular events. After the EKG, I was referred to a cardiologist who had me to wear a heart monitor for a week. On abnormal heart monitor for 7 days. I have had 12 supraventricular events. I am supposed to see my cardiologist in March. My blood pressure was also high at the time also.
Allergic to the Moderna COVID vaccine; This spontaneous case was reported by a patient and describes the occurrence of ALLERGY TO VACCINE (Allergic to the Moderna COVID vaccine) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALLERGY TO VACCINE (Allergic to the Moderna COVID vaccine). At the time of the report, ALLERGY TO VACCINE (Allergic to the Moderna COVID vaccine) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medications were reported. It was reported that the patient doctor had prescribed Paxlovid which the patient had not taken yet. The patient stated that she was allergic to the Moderna COVID vaccine and wanted to know if the ingredients in Paxlovid were similar to the ones in the Moderna COVID vaccine No treatment medications were reported.
The certified medical assistant (CMA) reported that the following improperly stored doses of vaccines administered to 3 patients on unspecified date: 3 doses of LIQUID PEDVAXHIB (dose, route, lot# not reported). No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Information has been received from a physician concerning a male who, "two weeks ago," on approximately 07-AUG-2007 was vaccinated with a dose of Zostavax (Oka/Merck).  "Two weeks ago," on approximately 07-AUG-2007 the patient experienced a localized redness reaction where the injection site was.  Unspecified medical attention was sought.  On an unspecified date, the patient recovered.  No product quality complaint was involved.  Additional information has been requested.
Chest pain (sharp stabbing pains, squeezing pain, pressure) Nausea Rash Dizziness  Body Fatigue and pain Elevated heart rate Fainting  I have been dealing with symptoms for over a year and finally received a diagnosis of chronic pericarditis this week. I have been suffering all of these symptoms, the chest pain and pressure impact my daily life and prevent me from my daily activities
Information has been received from a registered nurse concerning a female with a penicillin and aspirin allergy who was vaccinated with the first and second doses, respectively, of Recombivax HB. The RN reported that the patient developed a rash after receiving the first dose and was then hospitalized after the second dose. The RN did not know when the patient received the vaccine, but did state it was not within the last two years. The patient subsequently recovered. Additional information has been requested.
Severe pain in head, muscles, joints. Severe fatigue with chills and hot flashes. Air hurts my skin. When I am cold it feels like daggers piercing my skin. Nauseous. Diarrhea. Injection site tenderness. Fever up to 102.
Chest pains beginning 4/18 (a sharp pain near the center of my chest, just left of my breastbone), more consistently since 5/18; saw my doctor on 5/19 and 6/17; on 6/17 did an ECG and on 6/18 had a chest x-ray done. I went to a cardiologist 7/30 and scheduled a follow-up, but so far have not had any major chest pains since then
a muscular pain or tightness sensation around the back area around "the bra line"; a muscular pain or tightness sensation around the back area around "the bra line"; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 02Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Rheumatoid Arthritis" (ongoing). Concomitant medication(s) included: HUMIRA taken for rheumatoid arthritis (ongoing). The following information was reported: MYALGIA (non-serious), MUSCLE TIGHTNESS (non-serious) all with onset Mar2021, outcome "recovered" (Mar2021) and all described as "a muscular pain or tightness sensation around the back area around "the bra line"". Additional information: The events lasted for at least a few days (as reported).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
fever for 2 days and body aches.; dizziness; tremors throughout his body; cannot hold the cup of coffee; sicker than the first; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever for 2 days and body aches.), ILLNESS (sicker than the first), DIZZINESS (dizziness), TREMOR (tremors throughout his body) and ILLNESS (cannot hold the cup of coffee) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METOPROLOL and ATENOLOL for an unknown indication.   On 14-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 14-Feb-2021, the patient experienced ILLNESS (sicker than the first). On 17-Feb-2021, the patient experienced DIZZINESS (dizziness), TREMOR (tremors throughout his body) and ILLNESS (cannot hold the cup of coffee). On an unknown date, the patient experienced PYREXIA (fever for 2 days and body aches.). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (fever for 2 days and body aches.), ILLNESS (sicker than the first), DIZZINESS (dizziness), TREMOR (tremors throughout his body) and ILLNESS (cannot hold the cup of coffee) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant meds:Antihypertensive
About 24 hours after receiving vaccine, noticed very slight pain and small blistering in right cheek  area on face.   Did not think too much of it at first, however the area grew a little and swelled up.  Consulted with my doctor and they diagnosed Shingles.  Am currently prescribed Valtrex for shingles.
Information has been received from a physician concerning a 78 year old female with type 2 diabetes, chronic obstructive pulmonary disease and hypertension and no known drug allergies who on 10-NOV-2008 was vaccinated intramuscularly with the first 0.5 mL dose of PNEUMOVAX (LOT# 661529/0868X).  There was no concomitant medication.  On 18-NOV-2008 the patient experienced swelling and itching at the site of injection.  The patient was treated with TYLENOL, BENADRYL and cold compresses.  Subsequently, the patient recovered from the events.  The patient sought medical attention in the office.  This is one of several reports received from the same source.  Additional information has been requested.
CONSTIPATION; LETHARGY; COLD; SWEATING; MUSCLE WEAKNESS; CHILLS; MUSCLE ACHES/MYALGIA; FEVER; DARKLY COLOURED URINE; TREMOR; TINNITUS; LOSS OF APPETITE; STUFFINESS; This spontaneous report received from a patient concerned a 59 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included knee pain, alcohol user, and non-smoker, and other pre-existing medical conditions included the patient had no known allergies and he consumed alcohol no more than 2-3 drinks at any one time. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A expiry: 23-JUN-2021) dose was not reported, administered on 30-APR-2021 for prophylactic vaccination. Concomitant medications included celecoxib for knee pain, and minerals nos/vitamins nos. On 19-APR-2021, Laboratory data included: COVID-19 PCR test (NR: not provided) negative. On 24-APR-2021, Laboratory data included: COVID-19 PCR test (NR: not provided) NEGATIVE. On 30-APR-2021, Laboratory data included: COVID-19 PCR test (NR: not provided) Negative. On MAY-2021, the subject experienced stuffiness. Laboratory data included: Body temperature (NR: not provided) 99.6-99.8 F. Treatment medications included: paracetamol. On 06-MAY-2021, Laboratory data included: COVID-19 PCR test (NR: not provided) negative. On 09-MAY-2021, the subject experienced darkly coloured urine. On 09-MAY-2021, the subject experienced tremor. On 09-MAY-2021, the subject experienced tinnitus. On 09-MAY-2021, the subject experienced loss of appetite. On 09-MAY-2021, the subject experienced constipation. On 09-MAY-2021, the subject experienced lethargy. On 09-MAY-2021, the subject experienced cold. On 09-MAY-2021, the subject experienced sweating. On 09-MAY-2021, the subject experienced muscle weakness. On 09-MAY-2021, the subject experienced chills. On 09-MAY-2021, the subject experienced muscle aches/myalgia. On 09-MAY-2021, the subject experienced fever. On 12-MAY-2021, Laboratory data included: COVID-19 PCR test (NR: not provided) Negative. On 13-MAY-2021, treatment medications included: guaifenesin. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from darkly coloured urine on 15-MAY-2021, tremor, tinnitus, loss of appetite, constipation, lethargy, cold, sweating, muscle weakness, chills, muscle aches/myalgia, and fever on 17-MAY-2021, and stuffiness on MAY-2021. This report was non-serious.
injection site soreness; Can't lift my arm without pain/ unable to lift my left arm above my head without pain; It has affected every aspect of my life, incluiding bathing/washing my hair, shaving, working out, even my sex life; There is a lump on my arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 69 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 02Feb2021 (Batch/Lot number: unknown) at the age of 69 years as dose 1, single and intramuscular, administered in arm left, administration date 23Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "not recovered", described as "injection site soreness"; PAIN (non-serious) with onset 2021, outcome "not recovered", described as "Can't lift my arm without pain/ unable to lift my left arm above my head without pain"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 2021, outcome "unknown", described as "It has affected every aspect of my life, incluiding bathing/washing my hair, shaving, working out, even my sex life"; LIMB MASS (non-serious) with onset 2021, outcome "unknown", described as "There is a lump on my arm". Therapeutic measures were taken as a result of vaccination site pain, pain.  Additional information: There was no relevant tests.Specific relevant test for thromboembolic events with thrombocytopenic was none. Treatment received with Pain patches Ibuprofen for vaccination site pain, pain. It was reported that Your vaccine, given to me over six months, is still causing me injection site soreness and I can't lift my arm without pain.I am unable to lift my left arm above my head without pain. It has affected every a suspect of my life, including bathing/washing my hair, shaving, working out, even my sex life. There is a lump on my arm.  Follow-up attempts completed. No further information is expected.
This case was reported by a medical assistant and described the occurrence of ulcerative colitis in a 56 year old female patient who received hepatitis A inactivated and hepatitis B recombinant vaccine. Concurrent medications included Protonix, Effexor, Lactinex and Questran. Medical history was notable for no bowel problems prior to administration of Twinrix. On 3/10/04, the patient received the first dose of Twinrix. Approximately one day following the administration of the first dose of Twinrix, on 3/11/04, the patient developed blood in the stool, rectal bleeding, abdominal pain/cramping, gas and diarrhea. On 3/17/04, the patient was hospitalized with a diagnosis of ulcerative colitis. The colitis resolved on 3/19/04 and the patient was discharged from the hospital. On 4/9/04 the patient received the second dose of Twinrix. The following day, on 4/10/04, the patient experienced return of blood in the stool, rectal bleeding, abdominal pain/cramping, gas and diarrhea. She was hospitalized on 4/12/04 and prescribed prednisone, 40mg daily. By 4/20/04, she was supposed to begin tapering her dose of prednisone. By 4/22/04, when her dose of prednisone was tapered to 6 tablets, her symptoms began to return. As of 4/29/04, she was experiencing gas and white mucous in stools. Outcome of the other reported events was not specified.
pt recvd vax 16FEB96 & 19FEB96 had limpness spells x 1 w/eyes glazed over, pale color;no apnea;? poss sz;seen in office 23FEB96;
2-3 cm diameter subcutaneous nodule lasting approximately 3 weeks with accompanying 8-9 cm diameter patch of swelling/redness lasting approximately 1 week on right arm at injection site.
Had a fever first night home, 3rd day 5/5/2017 he developed a rash that was hot to touch around injection site. Ongoing.
Outbound call made 10/30/2020, spoke with Consumer. States that patient/patient's parents have not reported any adverse events after receiving a 3rd dose of MMRII.; Customer below called this morning to report off label use of MMRII Vaccine, vaccine was administered to patient 12 years of age whom had previously received 2 doses as per recommended schedule.; This spontaneous report has been received from the patient's parents referring to a 12 years old male patient (gender unknown). Information about concomitant medication, pertinent medical history, drug reactions or allergies was unknown.  On an unknown date (it was also reported as when the patient was 12 months), the patient was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (dose, frequency, route lot number, expiration date and indication were not reported) for prophylaxis. When the patient was 4 years old, the second dose of the vaccine was received as per recommended schedule. On 23-OCT-2020, the patient was vaccinated with a third dose off label use of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (frequency, route lot number, expiration date were not reported) for prophylaxis (extra dose administered). The patient's parents had not reported any adverse events after receiving the third dose of the vaccine. His parents would like to know if there were any recorded adverse events from any similar situations.
I am finding my ability to stand, walk, or hold my arms above my head for any period of more than a few minutes difficult. Yesterday I was unable to hold myself upright sufficiently to sit in a kayak (never got to find out for how long could I try to paddle). Mentally I am constantly having short-term memory challenges, for example just recalling the word fatigue to describe my situation I have had to write on a note paper as I repeatedly forget the term until I read it. Bringing groceries from our vehicle into the house I am finding near impossible (what used to take 1-2 minutes has taken me over 15 in the past 3 weeks on multiple occasions). I find myself falling asleep repeatedly during work, even though I am sleeping well at night. Some days are better than others, with a strong correlation to temperature.
Increase Temps; Increased Apnea; Bradycardia  4/1/08 Reviewed hospital medical records for 2/7-2/10/08. FINAL DX: none provided, no d/c summary available.  ER admit dx: ALTE, apnea & bradycardia w/febrile illness in extremely preemie infant. Records reveal patient home from NICU approx 1 mo on home monitor.  Seen by PCP 2/6 for vax & experienced fever, cough, congestion, increased apnea, multiple episodes of bradycardia, cyanosis.  Tx w/IV antibiotics.  LP done.
Numbness from injection site up to jaw, after approximately 30 min from onset  pain, numbness and tingling involved entire right arm. Warm compress, cold compress and Ibuprofen 400 mg po use as treatment. Symptoms totally resolved within 1 24 hrs.
Developed multiple seizures approximately 2 days post vax. Required hospitalization and child was prescribed phenobarbital. Was afebrile.
This initial spontaneous report was received from a medical assistant referring to unspecified number of patients of unknown ages and genders. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions described. The reporter stated that on unspecified dates, the patients received improperly stored doses of VARIVAX injection (lot # K005182 with expiration date 10-APR-2016 and lot# K006136 with expiration date 29-APR-2016; dose and route were not provided). No symptoms were reported. It was unknown if the patient sought medical attention. Product quality complaint (PQC) was not involved. Additional information has been requested.
Initial report received from a healthcare professional on 20 August 2013. A female patient (age at the time of event was not reported) had received an intramuscular dose of ADACEL (Lot number: C4313AA, anatomical site of vaccination was not reported) on an unspecified date. The patient was pregnant. The patient's last menstrual period date was unknown and estimated date of delivery was 24 October 2013. The patient's health during pregnancy and risk factors (e.g.: alcohol, tobacco or recreational drugs), treatment for infertility, medical history and concomitant medications were not reported. At the time of this report, the patient did not experience any adverse event. List of documents held by the sender: None.
The pharmacist injected the Shingrix vaccine subcutaneously instead of in the muscle and the injection site is still red, swollen, hot and painful 2 days later.  The induration is 6cm x 5cm and is 5 finger widths below the shoulder.
1st dose of shingrix received on  8/20/2019 and Dose 2 on 2/27/2021; This case was reported by a pharmacist via and described the occurrence of drug dose administration interval too long in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number EZ4TD, expiry date 4th November 2022) for an unknown indication.   Previously administered products included Shingrix (received 1st dose on 20th August 2019).   On 27th February 2021, the patient received the 2nd dose of Shingrix. On 27th February 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The patient received 2nd dose of Shingrix, more than the recommended interval, which led to lengthening of vaccination schedule. The reporter asked if patient needs another 2nd dose. The reporter consented to follow up.